182 related articles for article (PubMed ID: 36603378)
1. Knowledge and expectations about miRNAs as biomarkers in head and neck squamous cell cancers.
Galindo Torres BP; García Girón C; Alcaraz Ortega R; Saiz López P; Adiego Leza MI; Grijalba Uche MV
Am J Otolaryngol; 2023; 44(2):103771. PubMed ID: 36603378
[TBL] [Abstract][Full Text] [Related]
2. Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer.
Subha ST; Chin JW; Cheah YK; Mohtarrudin N; Saidi HI
Mol Biol Rep; 2022 Feb; 49(2):1501-1511. PubMed ID: 34837627
[TBL] [Abstract][Full Text] [Related]
3. Role of miRNA in head and neck squamous cell carcinoma.
Masood Y; Kqueen CY; Rajadurai P
Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
[TBL] [Abstract][Full Text] [Related]
5. Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.
Ganci F; Sacconi A; Manciocco V; Covello R; Benevolo M; Rollo F; Strano S; Valsoni S; Bicciato S; Spriano G; Muti P; Fontemaggi G; Blandino G
Mod Pathol; 2017 Oct; 30(10):1387-1401. PubMed ID: 28731048
[TBL] [Abstract][Full Text] [Related]
6. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
7. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
[TBL] [Abstract][Full Text] [Related]
9. microRNAs are important players in head and neck carcinoma: a review.
Janiszewska J; Szaumkessel M; Szyfter K
Crit Rev Oncol Hematol; 2013 Dec; 88(3):716-28. PubMed ID: 23948550
[TBL] [Abstract][Full Text] [Related]
10. Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature.
van Ginkel JH; Slieker FJB; de Bree R; van Es RJJ; Van Cann EM; Willems SM
Oral Oncol; 2017 Dec; 75():8-15. PubMed ID: 29224828
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.
Ahmad P; Sana J; Slavik M; Slampa P; Smilek P; Slaby O
Dis Markers; 2017; 2017():8245345. PubMed ID: 28325958
[TBL] [Abstract][Full Text] [Related]
13. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
15. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma.
Kogo R; Manako T; Iwaya T; Nishizuka S; Hiraki H; Sasaki Y; Idogawa M; Tokino T; Koide A; Komune N; Yasumatsu R; Nakagawa T
Cancer Med; 2022 Nov; 11(21):3960-3968. PubMed ID: 35352507
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
[TBL] [Abstract][Full Text] [Related]
17. The development of a liquid biopsy for head and neck cancers.
Schmidt H; Kulasinghe A; Kenny L; Punyadeera C
Oral Oncol; 2016 Oct; 61():8-11. PubMed ID: 27688098
[TBL] [Abstract][Full Text] [Related]
18. microRNAs deregulation in head and neck squamous cell carcinoma.
Carron J; Torricelli C; Silva JK; Queiroz GSR; Ortega MM; Lima CSP; Lourenço GJ
Head Neck; 2021 Feb; 43(2):645-667. PubMed ID: 33159410
[TBL] [Abstract][Full Text] [Related]
19. How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis.
Zhao G; Fu Y; Su Z; Wu R
Cell Physiol Biochem; 2018; 50(1):332-341. PubMed ID: 30282065
[TBL] [Abstract][Full Text] [Related]
20. [The Role of microRNA in head and neck cancer focusing on sinonasal carcinoma].
Kovaříková H; Chmelařová M; Palička V
Cas Lek Cesk; 2016; 155(2):45-50. PubMed ID: 27088793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
